Literature DB >> 1901601

Lysis of intraventricular hematoma with tissue plasminogen activator. Case report.

J M Findlay1, B K Weir, D E Stollery.   

Abstract

A 42-year-old woman suffered a severe intracerebral and intraventricular hemorrhage from a ruptured anterior cerebral artery aneurysm. Evacuation of the frontal hematoma and clipping of the aneurysm was performed but the intraventricular blood clot persisted, causing ventricular dilatation and high intracranial pressure (ICP) 24 hours after surgery despite external ventricular drainage. Over this period of time the patient's clinical condition improved from Grade V to Grade IVb (World Federation of Neurological Surgeons classification). The intraventricular hematoma was lysed with a total of 8 mg recombinant tissue plasminogen activator injected directly into the ventricles on the 1st and 2nd postoperative days, resulting in rapid normalization of ventricular size and ICP. The patient has since made a substantial recovery and has been able to return home.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901601     DOI: 10.3171/jns.1991.74.5.0803

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  Intraventricular Hemorrhage in Adults.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

Review 2.  Intraventricular fibrinolysis for intracerebral hemorrhage with severe ventricular involvement.

Authors:  Dimitre Staykov; Juergen Bardutzky; Hagen B Huttner; Stefan Schwab
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 3.  External ventricular drainage for intraventricular hemorrhage.

Authors:  Mahua Dey; Jennifer Jaffe; Agnieszka Stadnik; Issam A Awad
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 4.  Spontaneous intracerebral and intraventricular hemorrhage: advances in minimally invasive surgery and thrombolytic evacuation, and lessons learned in recent trials.

Authors:  Mahua Dey; Agnieszka Stadnik; Issam A Awad
Journal:  Neurosurgery       Date:  2014-02       Impact factor: 4.654

5.  Endogenous tissue plasminogen activator in neonatal cerebrospinal fluid.

Authors:  A Whitelaw; M C Mowinckel; V Fellman; U Abildgaard
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

6.  Lysis of basal ganglia haematoma with recombinant tissue plasminogen activator (rtPA) after stereotactic aspiration: initial results.

Authors:  B E Lippitz; L Mayfrank; U Spetzger; J P Warnke; H Bertalanffy; J M Gilsbach
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Management of intraventricular hemorrhage.

Authors:  Holly E Hinson; Daniel F Hanley; Wendy C Ziai
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

8.  Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage.

Authors:  L Mayfrank; B Lippitz; M Groth; H Bertalanffy; J M Gilsbach
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 9.  A review of stereotaxy and lysis for intracranial hemorrhage.

Authors:  Uzma Samadani; Veit Rohde
Journal:  Neurosurg Rev       Date:  2008-10-01       Impact factor: 3.042

Review 10.  Thrombolytic evacuation of intracerebral and intraventricular hemorrhage.

Authors:  Mahua Dey; Agnieszka Stadnik; Issam A Awad
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.